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Abstract
Introduction: There have been recent reports about a decline in dementia incidence, but only little is known about
trends in the mortality of patients with dementia. Only the simultaneous analysis of both trends can inform whether
the reported decline in dementia has led to a compression of dementia into higher ages.
Methods: We used health claims data from the largest public health insurer in Germany over the two time
periods 2004/07 and 2007/10. Dementia was defined according to the International Classification of Disease
10th revision (ICD-10) numbers G30, G31.0, G31.82, G23.1, F00, F01, F02, F03 and F05.1 or by a prescription of
cholinesterase inhibitors or memantine or both. In the two time periods, we observed 502,065 person-years of
exposure and 10,881 incident dementia cases and 10,013 person-years of exposure among the newly demented and
3049 deaths. We estimated the relative risks of the two time periods applying proportional hazard models and calculated
years with or without dementia using the illness-death model.
Results: Dementia incidence was significantly higher in 2006/07 than in 2009/10, whereas mortality with dementia
tended to be lower in the first period, albeit statistically significant among women only. Mortality without dementia
tended to be higher in the first period for men and remained stable for women. Combining these trends, we found that
at age 65 remaining life years with dementia were compressed by a yearly 0.4 months for men and 1.4 months for
women. At the same time, remaining life years without dementia increased by a yearly 1.4 months for men and
1.1 months for women.
Conclusions: This study provides evidence that the increase in dementia-free life years went together with an
absolute compression of life years with dementia. This positive trend was particularly strong among women.
Results were controlled for trends in multi-morbidity and care need, suggesting that the postponement in
dementia incidence is not simply caused by a delay in diagnosis.
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Introduction
The number of dementia cases worldwide is expected to
double every 20 years, resulting in 65.7 million individ-
uals with dementia by 2030 and 115.4 million by 2050
[1]. With 1.4 million patients with dementia in 2012,
Germany belongs to the top 10 countries with the lar-
gest number of patients with dementia worldwide. The
number is forecasted to increase up to three million by
2050 [2, 3]. A recent study showed that a yearly 1 % de-
cline in dementia prevalence can counterbalance the
effect of life expectancy (LE) increase on the number of
patients with dementia, resulting in considerably less
additional dementia cases than previously projected [2].
This interplay between incidence of dementia and
mortality of patients with dementia is of major interest
in terms of the broader framework of compression ver-
sus expansion of morbidity. Any extra years of life from
an overall increase in LE could be spent in good health,
which is referred to as compression of morbidity [4], or
in poor health termed expansion of morbidity [5]. Alter-
nately, unhealthy years may increase but do so as the
proportion of life spent healthily is increasing/decreas-
ing, resulting in a relative compression/relative expan-
sion [6]. Finally, morbidity might increase at a rate
similar to LE but severity might not, which is referred to
as “dynamic equilibrium” [7].
Recent secular trends in dementia suggest a decrease
in incidence rates, combined with stable or decreasing
prevalence. Turning to prevalence studies, Manton et al.
[8] observed a decline in severe cognitive impairment in
the US between 1982 and 1999; Langa et al. [9] observed
a continued decline between 1993 and 2002. There was
improved cognitive functioning among Danish [10] and
US [11] centenarians. Declining dementia was found by
Matthews et al. [12] in three regions in the UK between
1981/94 and 2008/11 and by Doblhammer et al. [3] in
Germany between 2007/09. In brain autopsies for the
period 1972 to 2006, the average amyloid stage de-
creased in cases without clinically diagnosed dementia
or cognitive disorders [13].
A number of recent incidence studies provided evi-
dence of declining trends. Schrijvers et al. [14] showed a
statistically not significant decline in incidence between
1990 and 2000 in Rotterdam, and Qiu et al. [15] inferred
a decline in incidence between 1987/89 and 2001/02
from a stable prevalence combined with decreasing mor-
tality in Stockholm.
Little is known about trends in the mortality of patients
with dementia. Studies based on death certificates indi-
cated increased mortality due to dementia and Alzheimer’s
dementia in the 1980s and the 2000s [16, 17]. Langa et al.
[9] compared the Health and Retirement Survey (HRS) of
1993–1995 with that of 2002–2004, finding a mortality in-
crease among the highly educated for those with moderate
or severe cognitive impairment. Using the HRS, Reuser
and Willekens [18] showed that people with high levels of
education have lower dementia incidence, but higher mor-
tality. Qiu et al. [15] found increasing survival of patients
with dementia in Stockholm.
In this study, we explored trends in the incidence of
dementia and in the mortality with and without demen-
tia. Combining this information, we estimated life years
with and without dementia to explore the presence of a
compression or expansion of dementia. We controlled
for trends in co-morbidity and care need to test whether
a shift in the general health status of the population may
explain these trends. Based on the results of the prior
studies, a decline in dementia incidence would be ex-
pected. Given past contradictory research results, no ex-
plicit hypothesis about the trend in mortality of patients
with dementia was formulated. General improvements
in health and survival may reduce the incidence of de-
mentia [19] but may also benefit patients with dementia
in terms of their co-morbidities, possibly increasing their
LE [20]. On the other hand, increasing educational levels
may lead to increasing cognitive reserve [21]. Cognitive
reserve is a key concept in the study of cognitive func-
tioning. It stems from the repeated observation that
there is no straightforward relationship between the
degree of brain pathology and cognitive functioning.
A high level of educational attainment or a demand-
ing occupation allows individuals to process tasks in
a more efficient manner and thus to sustain greater
brain damage before displaying major functional defi-
cits. Increasing cognitive reserve would result in a
later diagnosis [22] and in what would appear to be
shorter survival rates.
We also examined the distribution of the new demen-
tia cases. A decline in age-specific dementia incidence
should go hand in hand with a postponement of demen-
tia to higher ages, thus increasing the mean age of the
new dementia cases.
Methods
Study design and participants
We compared two random samples of health claims data
from Germany’s largest public health insurance, the “All-
gemeine Ortskrankenkasse” (AOK), which covers about
one third of the total population at least 50 years old
and 50 % of the population at least 80 years old. An age-
stratified 2.2 % random sample of the insured population
at least 63 years old was drawn from all insured persons
in the first quarter of 2004 and tracked through the
fourth quarter of 2007. Incident dementia was defined
for all individuals without a dementia diagnosis in the 2-
year period 2004/05 and a first dementia diagnosis in
2006 or 2007. Thus, at the time of diagnosis, they would
be at least 65 years old. A second independent 2.2 %
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random sample was drawn in the first quarter of 2007
with follow-up through the last quarter of 2010. Incident
dementia was defined by a dementia-free period in
2007/08, and a first dementia diagnosis in 2009 or 2010.
Only validated dementia cases were considered (for the
validation procedure, see below). Death rates were esti-
mated for the two time periods 2006/07 and 2009/10 for
individuals with an incident dementia diagnosis only;
separate death rates were estimated for those without
dementia. The data included information about sex, age,
all inpatient and outpatient diagnoses coded by Inter-
national Classification of Disease 10th revision (ICD-10),
prescriptions of medications filled on a quarterly basis,
and whether patients received benefits or services from
the German statutory long-term care (LTC) insurance.
Data access was legally approved by the “Wissenschaf-
tliches Institut der Ortskrankenkassen” (WIdO). The
study is based on anonymised administrative claims data
that never involved patients directly. Individual patients
cannot be identified, and the analyses presented do not
affect patients whose anonymized records were used.
Measurement of dementia
Dementia was defined by the ICD-10 numbers G30,
G31.0, G31.82, G23.1, F00, F01, F02, F03, and F05.1 or
by a prescription of cholinesterase inhibitors or meman-
tine (or both), both of which are approved anti-dementia
drugs. We did not distinguish according to aetiology,
but combined all ICD codes into one group named “de-
mentia”. To account for false-positive diagnoses of the
true occurrence of dementia [23], we developed a valid-
ation procedure. First, only diagnoses indicated as “veri-
fied” by a medical doctor were included from outpatient
services, whereas from inpatient services only the dis-
charge and secondary diagnoses were considered. Sec-
ond, only those diagnoses with a second occurrence in
the same quarter by different types of physicians or over
time were considered. The only exception was when a
patient died immediately after a dementia diagnosis in
the same quarter; all of these cases were considered valid
dementia cases.
Co-variates
We measured changes in the general health status of the
population by controlling for the diagnosis of hyperten-
sion (ICD-10 Codes: I10-I15), diabetes mellitus (E10-
E14), ischemic heart diseases (I20-I25), cerebrovascular
diseases (I60-I69), hypercholesterolemia (E78), and atrial
fibrillation (I48). We used benefits from the German
public LTC insurance as an indirect measure of the se-
verity of a dementia diagnosis. The insurance was estab-
lished in 1995 and is financed as a pay-as-you-go
system. To claim LTC benefits or services from the in-
surer, individuals have to make an application and pass
an objective assessment, which is based mainly on im-
pairments in activities of daily living. Applicants are
assigned to one of three LTC levels: considerable, severe,
or extreme. People who have a considerable level of LTC
require care for at least 90 min per day, of which at least
46 min are needed for basic activities like washing, eat-
ing, or mobility. People with a severe level of LTC re-
quire care for at least 3 h per day, with at least 2 h
needed for basic activities. People with an extreme level
of LTC require care for at least 5 h per day, of which at
least 4 h are needed for basic activities. LTC here com-
prises day care, home care by nurses or non-professionals
as well as care in a nursing care home.
Statistical analyses of trends in incidence and death rates
We estimated the relative risks (RRs) of dementia inci-
dence and mortality with/without dementia in 2006/07
compared with 2009/10 by applying proportional hazard
models with constant baseline hazards defined over the
calendar time of the two time periods. The timescale of
the baseline hazard is months since 2006 (2009). The
models include an indicator variable for both time pe-
riods, age in 1-year age groups (defined as a second-
degree polynomial and centered at age 80, the middle of
the age interval), the co-morbidities, and the care level
differentiated into none (care level 0), considerable (care
level I), severe (care level II), and extreme (care level III).
All covariates are specified as time-dependent variables.
Individuals are censored at the time of their death (inci-
dence model), their exit from the insurance company
(incidence and mortality models), or the end of the ob-
servation period (incidence and mortality models),
whichever occurred first. The proportionality assump-
tion was tested by estimating the -ln(-ln) Kaplan-Meier
survivor curves [24]. All proportional hazard models
were estimated separately for both sexes. We conducted
sensitivity analyses to test whether the results depended
on the parametric form of the baseline hazard using a
piecewise constant hazard rate, which was not the case.
We also ran models using age at baseline applying Cox
proportional hazard models which, again, did not alter
the results. Whereas death rates were higher, the time
trend remained unchanged. We used the procedure
“streg” in STATA 12.1 for the estimation of the hazard
models and the post-estimation command “predict” for
the calculation of the hazard rates fitted by the models.
Estimating life years with and without dementia
We used the illness-death model, which has been fre-
quently applied to dementia research [20], to estimate
life years with and without dementia and explore com-
pression of dementia. The model is defined by two living
states, non-demented and demented, and three period
and sex-specific transitions: non-demented to demented,
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non-demented to death, and demented to death. We
estimated the age-specific transition rates by fitting sep-
arate hazard models to the two time periods and the two
sexes, only including the second-degree age-polynomials.
We estimated the average LE at age 65 with dementia
(LE dementia 65) and without dementia (LE w/o dementia 65) as
well as the distribution of the new dementia cases D (x) at
age x (for model details see “Additional file 1”). We boot-
strapped 95 % confidence intervals by re-sampling the
sample data with replacement. We performed a thousand
replications each time estimating the age-specific transi-
tion rates by the hazard models and the LEs by the illness-
death models.
Results
Time trends estimated with proportional hazard models
In the two time periods, there were a total of 10,881 inci-
dent dementia cases with 502,065 person-years of expos-
ure (PYE). Among the non-demented, we observed 16,961
deaths with 500,714 PYE, among the newly demented
3049 deaths with 10,013 PYE (Table 1). Age-specific num-
bers and rates are given in the supplement (“Additional
file 2: Table S1”). Total death rates were slightly higher as
compared with the human mortality database [25], reflect-
ing the bias toward lower social strata insured with the
AOK. As expected, dementia incidence was slightly higher
but highly consistent with results from previous studies
(for an overview, see [26]) (Fig. 1).
The RRs of the two time periods estimated by propor-
tional hazard models confirmed highly significant changes
in the incidence of dementia as well as in death rates of
demented women (Table 2). For both sexes, the incidence
of dementia was significantly higher in the first period
of 2006/07 (RR men: 1.10, P value = 0.006; RR women:
1.10, P value = 0.000) than in 2009/10. For men, mor-
tality without a dementia diagnosis was somewhat
higher in the first than the second period (RR men:
1.04, P value = 0.075), whereas mortality for women
remained stable (RR women: 1.00, P value = 0.935).
Mortality with a dementia increased for both sexes; in
the first period, it was somewhat lower for men (RR
men: 0.90, P value = 0.084) and significantly lower for
women (RR women: 0.83, P value = 0.000). Time trends did
not change when co-morbidities were accounted for
(Additional file 3: Table S2).
Life years with/without dementia estimated with the
illness-death model
Predicted hazard rates from the incidence and mortality
models fitted the observed values well (Fig. 2). Using the
predicted rates as the input into the illness-death model,
we found more years lived healthily and a compression of
years with dementia. Among men, trends in incidence and
death rates amounted to an increase of 4.8 healthy months
(Table 3: LEw/o dementia 65 2006/07: 14.79 years, 2009/10:
15.14 years; difference = 0.35 years) and to a decrease
of 1.1 months with dementia (LE dementia 65: 2006/07
0.96 years, 2009/10: 0.87 years, difference = −0.09 years)
within 3 years. The increase in healthy life years was weakly
significant at P = 0.084. Among women, the decrease in
months with dementia was highly significant (P = 0.000)
and stronger than the gain in healthy life months:
minus 4.1 months with dementia (LE dementia 65 2006/
07: 1.87 years, 2009/10: 1.53 years, difference = −0.34 years)
compared with 3.2 healthy months (LEw/o dementia 65 2006/
07: 18.14 years, 2009/10: 18.41 years, difference =
0.27 years).
Mean age of dementia incidence
In the illness-death model, the mean of the distribution
of new dementia cases (Fig. 3) increased from 80.54 to
80.80 years among men and 82.47 to 82.71 years among
women, albeit this increase was statistically not signifi-
cant. The variance of the distribution declined from
Table 1 Descriptive statistics of the number of insured individuals, exposures in person-years and cases at ages 65 to 95+ in the
two time periods by sex
Model 2006/2007 2009/2010 Total
Men Women Men Women
Dementia incidence N 56,011 85,081 54,257 80,986 276,335
Exposures + 100,034 154,962 98,358 148,711 502,065
Incident dementia 1811 3768 1781 3521 10,881
Mortality without dementia diagnosis N 55,684 84,377 53,955 80,357 274,373
Exposures + 99,806 154,498 98,136 148,274 500,714
Deaths 3993 4463 4001 4504 16,961
Mortality with incident dementia diagnosis N 1810 3769 1781 3520 10,880
Exposures + 1594 3694 1497 3228 10,013
Deaths 579 912 598 960 3049
+in person years
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53.88 to 53.08 for men and increased from 46.85 to
47.99 for women. This was combined with a 3.3 % de-
crease in the number of new dementia cases among men
and 5.0 % among women. Thus, in the latter period,
there were less new dementia cases among men and they
tended to be compressed into higher ages. Also, among
women, there were fewer dementia cases and the mean
was shifted to older ages. However, the age distribution
became more unequal in terms of variance.
Discussion
We report a compression of life years with dementia for
ages of 65 and above, caused by a significant short-term
decrease in the dementia incidence in Germany between
2006/07 and 2009/10. Among both sexes, the compres-
sion was intensified by a parallel increase in the death
rates of the demented. For women, the significant com-
pression amounted to 1.4 months per year, and men
tended to gain almost half a month per year. At the
same time, both sexes experienced more healthy life
years due to the decreasing incidence. Women gained
1.1 healthy months per year, and men 1.4 months; how-
ever, these trends were statistically significant among
men only. This declining incidence was associated with
an increase in the mean age of dementia incidence.
Our study suggests that declining incidence does not ne-
cessarily lead to a concentration of new dementia cases
into a smaller age range. Among men, the declining
incidence indeed resulted in a concentration of the ages at
first diagnosis since the variance of the distribution became
smaller; among women; however, the variance increased
and the ages at first diagnosis became more variable. Male
death rates at the ages studied here are about twice those
of females. Thus, men spared from dementia at younger
ages die before they suffer from dementia at older ages,
whereas comparatively more women survive without de-
mentia and then suffer from dementia at older ages. Owing
to the short time period of this study, the observed distri-
butional changes are statistically not significant. Longer
time periods are necessary to finally confirm the trends
observed here.
Comparison with results from earlier studies
The decline in dementia incidence reflects results of re-
cent studies [14] (for a review, see [27]). The extent of
the yearly 3 % decline is similar to the one reported in
the Rotterdam Study [14]. Larson et al. [22] suggest that
the main factor contributing to the decline is increas-
ingly higher educational attainment among the elderly,
which resulted in increasing cognitive reserve [21]. In
the age groups studied here, both sexes profited from
the educational expansion after World War I in Germany,
and women in particular profited from vocational train-
ing from the 1920s to the 1950s [28]. In the HRS
[29], the increasing levels of education and wealth
among older Americans explained about 40 % of
Fig. 1 Comparison of dementia incidence rates (AOK 2006/07 and 2009/10) with previous studies. AOK Allgemeine Ortskrankenkassen
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the observed relative decrease in the prevalence of
dementia-related cognitive impairment between 1993
and 2002. In the Stockholm Study [15], no changes in
the prevalence of dementia or in the death rates
of the demented remained once education was
accounted for. We do not have information on educa-
tion in our data and thus are not able to further ex-
plore the contribution of education to the declining
trend in dementia incidence. We tried to capture
possible time trends in vascular risk factors [30] of
dementia by including related co-morbidities in our
model. Although the effects of the co-morbidities
altered the risk of dementia incidence and mortality
according to our expectations, they did not affect the
estimates of the time trends. Thus, we find no evi-
dence that a change in the distribution of vascular
Fig. 2 Observed and predicted values for (a) dementia incidence rates, (b) death rates of the demented, and (c) death rates of the non-demented for
the periods 2006/07 and 2009/10 by sex (logarithmic scale)
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risk factors, as reflected in co-morbidities, contributed
to the short-term decline in dementia incidence.
Trends in dementia incidence
There are at least three potential explanations that may
account for the declining dementia incidence we ob-
serve. The first explanation assumes that the timing of
dementia diagnosis has changed rather than the inci-
dence of the disease. In claims data, the timing of
dementia diagnosis is not identical with the exact inci-
dence of the disease. If diagnosis tends to be delayed
over time until patients have reached a more severe
stage of the disease, then age-specific diagnosis rates
would decline. At the same time, those diagnosed would
have worse health, leading to an increase in age-specific
death rates. As claims data do not contain information
about the severity of dementia, we tried to control for a
possible delay in the diagnosis by including information
about co-morbidity and care need in our models (shown
in “Additional file 3: Table S2”). If over the study period
dementia diagnosis was delayed to a more severe stage,
then patients should suffer from more co-morbidities
and should require more care assistance. In the models,
the time trend in dementia should thus be attenuated by
the inclusion of the two variables. However, this is not
what we find, because the time trend remained unchanged.
Table 2 Relative risks of dementia incidence and mortality with and mortality without dementia for the two sexes
Model Variable Men Women
RR P value LCI UCI RR P value LCI UCI
Dementia incidence Age 1.13 0.000 1.12 1.13 1.14 0.000 1.14 1.15
Age*Age 9.99 0.001 9.99 10.00 9.98 0.000 9.97 9.98
Period
2006/2007 1.10 0.006 1.03 1.17 1.10 0.000 1.05 1.15
2009/2010 (RG) 1 1 1 1 1 1
Constant 0.03 0.000 0.03 0.03 0.03 0.000 0.03 0.03
LL −18,278.2 −34,580.6
Mortality without dementia diagnosis Age 1.09 0.000 1.08 1.09 1.11 0.000 1.11 1.12
Age*Age 10.01 0.000 10.00 10.01 10.01 0.000 10.01 10.01
Period
2006/2007 1.04 0.075 1.00 1.09 1.00 0.935 0.96 1.04
2009/2010 (RG) 1 1 1 1 1 1
Constant 0.06 0.000 0.06 0.06 0.03 0.000 0.03 0.03
LL −35,303.3 −40,513.3
Mortality with incident dementia diagnosis Age 1.05 0.000 1.04 1.06 1.05 0.000 1.04 1.06
Age*Age 10.01 0.005 10.00 10.02 10.01 0.006 10.00 10.02
Period
2006/2007 0.90 0.084 0.81 1.01 0.83 0.000 0.76 0.91
2009/2010 (RG) 1 1 1 1 1 1
Constant 0.37 0.000 0.34 0.41 0.22 0.000 0.21 0.24
LL −4,173.1 −6,941.1
RR relative risk, LCI 95 % lower confidence interval, UCI 95 % upper confidence interval
+E-10
Table 3 Life expectancy at age 65 with and without dementia and mean age of new dementia cases, 95 % confidence intervals by
sex: 2006/07 in comparison with 2009/10
Total Non-dementia Dementia Mean age
Males 2006/2007 15.75 (15.58-15.94) 14.79 (14.62–14.96) 0.96 (0.90–1.03) 80.54 (80.27–80.82)
2009/2010 16.01 (15.85-16.19) 15.14 (14.98–15.32) 0.87 (0.82–0.93) 80.80 (80.53–81.09)
P = 0.224 P = 0.084 P = 0.180 P = 0.446
Females 2006/2007 20.01 (19.86-20.17) 18.14 (18.00–18.29) 1.87 (1.78–1.97) 82.47 (82.29–82.66)
2009/2010 19.93 (19.77-20.10) 18.41 (18.26–18.56) 1.53 (1.46–1.60) 82.71 (82.52–82.91)
P = 0.706 P = 0.148 P = 0.000 P = 0.310
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Thus, there is no indication that dementia diagnosis was
delayed to a more severe stage. In recent years, public
health programs have tried to increase awareness about the
disease both in the general population [31] as well as
among the medical profession [32]. First generic anti-
dementive drugs were introduced in 2012, which should
have made treatment less costly but does not fall into our
study period.
A second alternative explanation is that the declin-
ing incidence reflects an improvement in general
health over time. Most recently, it has been suggested
that late-life dementia can best be understood in
terms of overall health status rather than specific risk
factors [19]. A series of studies has shown that phys-
ical health measured in terms of functional limitations
has improved over time, leading to better functioning
in more recent cohorts. At the same time, the preva-
lence of morbidity has increased (for a review, see
Christensen et al. [33]). Our results suggest that the
decline in dementia incidence is independent of
trends in selected co-morbidities. These trends, how-
ever, may in part only show trends in general health
and might in part reflect improved medical know-
ledge and health-service use in elderly people, without
changes in underlying conditions [34].
A third explanation is that cognitive reserve had in-
creased over time, which would lead to a decline in inci-
dence rates and an increase in death rates [22].
However, claims data do not contain information about
educational or occupational background (or both) of the
insurants and thus we were not able to test this hypoth-
esis explicitly. However, we will come back to this poten-
tial explanation below.
Trends in the mortality of patients with dementia
Although only few studies report trends in the mortality
of patients with dementia, these tend to report mixed re-
sults: increasing trends in health claims data [16, 17] and
the HRS [9], a declining trend in the Stockholm Study
[15]. However, none of these studies was able to explore
sex-specific trends because of the small numbers in-
volved. One explanation for the increasing mortality
may be changes in cognitive reserve due to the educa-
tional expansion after World War I and the opening of
career possibilities after World War II [28]. This would
result in a later diagnosis of dementia but also shortened
survival thereafter [9, 18]. Trends in educational expan-
sion might also explain why the compression was stron-
ger for women than for men. It has been pointed out
that, in the 20th century, German women’s educational
levels, labour force participation rates, and access to car-
eer opportunities underwent tremendous changes, even
more than for men [35]. In addition, European women
gained more than men from societal improvements over
time, thereby increasing their general cognitive ability
more than men [36].
Trends in risk factors of dementia
Recent studies have highlighted that the reduction of
vascular risk factors in mid and late life not only in-
creased LE but also led to a lower risk of late-life de-
mentia [20]. Further progress may thus be derived
from public health interventions that lead to changes
in lifestyle. Changes in dietary habits [37], such as
following the Mediterranean diet more closely [38]
and increased physical activity [39], have the highest
potential to contribute to a delay in or the prevention
Fig. 3 Distribution of new dementia cases in the illness-death model
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of dementia. In addition to single risk factors, it has
been shown that overall health status is a major or
contributing risk factor of dementia [19] and that a
focus on cardiometabolic risk factors may be too lim-
ited [40]. Educational levels and wealth have been
continuously increasing among today’s elderly [28],
and poverty levels are low. Although these trends
are expected to continue in the near future, short-
ened and broken working careers coupled with less
generous retirement schemes in the coming genera-
tions will eventually lead to higher levels of old-age
poverty.
Although our study does not permit any cohort
analysis, the positive trends we observe today may be
partially due to the favourable mid- and late-life con-
ditions for cohorts born before World War II, to
which the study participants belong. This trend may,
however, diminish in subsequent generations. The end
of World War II may also play an important role in
terms of a reduction of people affected by post-
traumatic stress disorder (PTSD) throughout the co-
horts. With some exceptions, the last German male
cohorts actively involved in combat are those born in
1927 who were 17 years old at the end of World
War II and were 79 years or older in our study. Co-
horts born before 1927 had a high risk of suffering
from PTSD due to combat and war imprisonment.
Recent research has highlighted the long-term effects
of traumatic brain injury and PTSD on dementia later
in life [41, 42]. Although little is known about PTSD
as a risk factor of dementia, it can be a chronic con-
dition which is related to depression, head injury, or
medical co-morbidities, all conditions associated with
both PTSD and dementia. An alternative explanation
is that PTSD might be related to accelerated brain
ageing [43].
In increasingly ethnically diverse older populations,
certain ethnic groups may be at a higher risk of de-
mentia, which may slow down improvements in the
occurrence of dementia. In Germany, for example, the
Turkish foreign population was and still is the largest
of the immigrant groups [44]. The majority of the mi-
grants from Turkey arrived as so-called guest workers
who were recruited by the Federal Republic of Germany
between 1961 and 1973. These migrants are now ageing
and in general have similar LE but worse health than their
German native counterparts, particularly women. Both
the young and the elderly have less education and wealth
[45] and higher obesity rates [46]. Rising levels of obesity
[47] in combination with metabolic diseases [48] pose
another challenge for reducing dementia in the fu-
ture, particularly in low- and middle-income coun-
tries [40]. Public health interventions at the individual
and societal level, together with intensified research on
developing preventive drugs as well as more effective
treatments, will be necessary.
Strengths and weaknesses of the data
The primary aim of German health claims data is cost
calculation and reimbursement rather than documenta-
tion of disease. This may lead to various distortions re-
garding false-positive and false-negative diagnoses.
Although we did develop an internal validation proced-
ure to deal with false-positive diagnoses, we were not
able to identify false-negative diagnoses. However, a
study comparing dementia diagnoses based on Medicare
claims data with diagnoses based on [23] found that
Medicare claims tend to overestimated the true preva-
lence of dementia. In a previous study, we showed that
the prevalence of dementia compares well with results
from international studies [3], which is also true for the
incidence in this study. There were no major legal
changes or changes in the cost calculation software dur-
ing the study period, and the increasing knowledge and
awareness of physicians and patients cannot explain the
decrease in incidence as well as prevalence [3]. Health
claims data cover the total population, including people
living in nursing homes where the prevalence of demen-
tia is four times higher than for non-residents [49]. Be-
cause we use a random sample of the total population,
study design or self-selection biases do not exist. The
large number of cases allowed us to conduct a detailed
analysis of incidence and mortality up through the high-
est ages. The socio-economic status of the company’s
insurants is lower than that of the general population
[50], but this is largely among younger people. Changes
in the social status composition of the insured popula-
tion are negligible in the time period studied here.
Limitations of the illness-death model
Our analysis rests on three assumptions. First, the
illness-death model, like all life tables, assumes a station-
ary population with no changes in age-specific rates
[51]; that is, for each of the two periods, LE is calculated
under the assumption that the age-specific rates will re-
main constant until the last member of the cohort has
reached the highest age. Because we show changes in de-
mentia incidence and mortality over time, our LEs de-
pict the disease regime in a given year rather than in the
future years of a 65-year-old which will be lived healthily
or with dementia. If the decline in the dementia inci-
dence continues, then the healthy life years are underes-
timated, whereas continuous increases in the mortality
rate of the demented would cause an overestimation of
life years with dementia. The second assumption is that
we do not observe the ageing of one specific birth co-
hort over the whole age range, but rather we use a syn-
thetic cohort constructed from two cross-sections with a
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short-term follow-up. Thus, our approach is essentially
cross-sectional, depicting period rather than cohort LE.
The third is that the model does not consider recovery
from dementia, which reflects the fact that at present
dementia cannot be treated. Mild cognitive impairment
is not part of our model. Recent studies show that pa-
tients with mild cognitive impairment have a high risk of
progressing to dementia, even if they had reverted to
normal cognitive functioning [52]. Thus, in our data, we
start to include them only once they have received their
first dementia diagnosis.
Conclusions
Using population-based medical claims data for Germany,
we found a compression of life years with dementia by a
yearly 1.4 months for women and almost half a month for
men. The compression was due to declining incidence
rates and increasing death rates of the demented. The
scale of reduction in the incidence of dementia is compar-
able to earlier results. In Germany, in the age groups stud-
ied here, both sexes profited from the educational
expansion after World War I and better living conditions
after World War II. In addition, vascular risk factors of de-
mentia have declined and are better controlled. In terms
of future numbers of patients with dementia, the increase
might be smaller than previously expected. An open ques-
tion is whether increasing obesity levels and the changing
social composition of the elderly might counterbalance
positive developments observed in the past.
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